QTTB · Categories · Downgrades
QTTB - Analyst downgrades
Q32 Bio Inc. (QTTB) analyst downgrades - real-time wire coverage filtered to Downgrades only.
Recent Downgrades for QTTB
- Q32 Bio downgraded by BMO Capital Markets with a new price targetBMO Capital Markets downgraded Q32 Bio from Outperform to Market Perform and set a new price target of $3.00 from $22.00 previously
- Q32 Bio downgraded by Piper Sandler with a new price targetPiper Sandler downgraded Q32 Bio from Overweight to Neutral and set a new price target of $4.00 from $20.00 previously
- Q32 Bio downgraded by GuggenheimGuggenheim downgraded Q32 Bio from Buy to Neutral
- Q32 Bio downgraded by Wells Fargo with a new price targetWells Fargo downgraded Q32 Bio from Overweight to Equal Weight and set a new price target of $16.00 from $95.00 previously
- Q32 Bio downgraded by Raymond James with a new price targetRaymond James downgraded Q32 Bio from Strong Buy to Outperform and set a new price target of $22.00 from $90.00 previously
- Q32 Bio downgraded by Leerink Partners with a new price targetLeerink Partners downgraded Q32 Bio from Outperform to Market Perform and set a new price target of $9.00 from $68.00 previously